Display options
Share it on

Front Genet. 2012 Mar 28;3:46. doi: 10.3389/fgene.2012.00046. eCollection 2012.

Regulation of miRNA 219 and miRNA Clusters 338 and 17-92 in Oligodendrocytes.

Frontiers in genetics

Omar de Faria, Qiao-Ling Cui, Jenea M Bin, Sarah-Jane Bull, Timothy E Kennedy, Amit Bar-Or, Jack P Antel, David R Colman, Ajit S Dhaunchak

Affiliations

  1. Department of Neurology and Neurosurgery, Montreal Neurological Institute and Hospital, McGill University Health Centre, McGill University Montreal, QC, Canada.

PMID: 22470405 PMCID: PMC3314186 DOI: 10.3389/fgene.2012.00046

Abstract

MicroRNAs (miRs) regulate diverse molecular and cellular processes including oligodendrocyte (OL) precursor cell (OPC) proliferation and differentiation in rodents. However, the role of miRs in human OPCs is poorly understood. To identify miRs that may regulate these processes in humans, we isolated OL lineage cells from human white matter and analyzed their miR profile. Using endpoint RT-PCR assays and quantitative real-time PCR, we demonstrate that miR-219, miR-338, and miR-17-92 are enriched in human white matter and expressed in acutely isolated human OLs. In addition, we report the expression of closely related miRs (miR-219-1-3p, miR-219-2-3p, miR-1250, miR-657, miR-3065-5p, miR-3065-3p) in both rodent and human OLs. Our findings demonstrate that miRs implicated in rodent OPC proliferation and differentiation are regulated in human OLs and may regulate myelination program in humans. Thus, these miRs should be recognized as potential therapeutic targets in demyelinating disorders.

Keywords: differentiation; microRNA; myelination; oligodendrocyte precursor cell

References

  1. Genome Biol. 2004;5(3):R13 - PubMed
  2. Am J Pathol. 2004 Dec;165(6):2167-75 - PubMed
  3. Proc Natl Acad Sci U S A. 2007 Nov 6;104(45):17813-8 - PubMed
  4. Nature. 2005 Jun 9;435(7043):828-33 - PubMed
  5. Genome Biol. 2007;8(2):R19 - PubMed
  6. Dis Model Mech. 2009 Mar-Apr;2(3-4):178-88 - PubMed
  7. Oncogene. 2007 Sep 6;26(41):6099-105 - PubMed
  8. Methods. 2008 Jan;44(1):31-8 - PubMed
  9. Brain. 2009 Dec;132(Pt 12):3342-52 - PubMed
  10. Genome Res. 2004 Dec;14(12):2486-94 - PubMed
  11. J Neurobiol. 1995 Feb;26(2):283-93 - PubMed
  12. Neuron. 2010 Mar 11;65(5):612-26 - PubMed
  13. Methods. 1998 Nov;16(3):282-92 - PubMed
  14. Genome Res. 2009 Jan;19(1):92-105 - PubMed
  15. Anal Biochem. 1999 May 15;270(1):41-9 - PubMed
  16. Development. 2010 Jul;137(13):2127-32 - PubMed
  17. Nat Neurosci. 2006 Feb;9(2):173-9 - PubMed
  18. Anal Biochem. 2000 Oct 15;285(2):194-204 - PubMed
  19. J Neurosci. 2008 Nov 5;28(45):11720-30 - PubMed
  20. Nucleic Acids Res. 2006 Jan 24;34(2):e9 - PubMed
  21. Neuron. 2010 Mar 11;65(5):577-9 - PubMed
  22. Cell. 2008 Mar 7;132(5):875-86 - PubMed
  23. J Neuropathol Exp Neurol. 2010 Sep;69(9):930-44 - PubMed
  24. Cancer Res. 2004 May 1;64(9):3087-95 - PubMed
  25. Nat Rev Neurosci. 2005 Sep;6(9):683-90 - PubMed
  26. Nucleic Acids Res. 2005 Nov 27;33(20):e179 - PubMed
  27. Nat Med. 2004 Jan;10(1):93-7 - PubMed
  28. J Neurosci. 2011 Oct 19;31(42):14961-71 - PubMed
  29. Cancer Res. 2005 Nov 1;65(21):9628-32 - PubMed
  30. Neuron. 2010 Mar 11;65(5):597-611 - PubMed
  31. Science. 2010 Nov 5;330(6005):779-82 - PubMed
  32. Glia. 2010 Dec;58(16):1949-60 - PubMed
  33. PLoS One. 2010 May 05;5(5):e10480 - PubMed

Publication Types